Zacks Research upgraded shares of Acadia Healthcare (NASDAQ:ACHC – Free Report) from a hold rating to a strong-buy rating in a report published on Monday morning,Zacks reports.
Several other research analysts have also issued reports on the company. Raymond James Financial started coverage on Acadia Healthcare in a research report on Wednesday, November 4th. They set a “moderate buy” rating on the stock. Barclays raised their price target on Acadia Healthcare from $32.00 to $35.00 and gave the stock an “equal weight” rating in a report on Thursday, November 5th. Royal Bank Of Canada boosted their price target on Acadia Healthcare from $31.00 to $41.00 and gave the stock an “outperform” rating in a research note on Friday. Guggenheim upped their price objective on shares of Acadia Healthcare from $39.00 to $41.00 and gave the company a “buy” rating in a report on Friday, November 6th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare has an average rating of “Moderate Buy” and a consensus target price of $32.54.
View Our Latest Analysis on ACHC
Acadia Healthcare Trading Up 0.1%
Shares of NASDAQ ACHC opened at $38.64 on Monday. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 1.60. The stock has a market capitalization of $3.59 billion, a P/E ratio of -3.10, a price-to-earnings-growth ratio of 11.08 and a beta of 0.64. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $39.70. The business has a fifty day moving average price of $29.83 and a 200 day moving average price of $26.38.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.14. The company had revenue of $895.31 million during the quarter, compared to the consensus estimate of $877.76 million. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.53%. Acadia Healthcare’s revenue was up 5.1% compared to the same quarter last year. During the same period last year, the firm earned $0.72 earnings per share. Equities research analysts expect that Acadia Healthcare will post 1.74 EPS for the current fiscal year.
Hedge Funds Weigh In On Acadia Healthcare
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. Clough Capital Partners L P purchased a new position in shares of Acadia Healthcare in the first quarter worth about $5,359,000. Deutsche Bank AG acquired a new stake in shares of Acadia Healthcare during the second quarter worth about $49,746,000. Bank of America Corp DE acquired a new stake in shares of Acadia Healthcare during the second quarter worth about $21,606,000. Lisanti Capital Growth LLC purchased a new stake in Acadia Healthcare in the second quarter valued at approximately $4,502,000. Finally, Royal Bank of Canada boosted its position in Acadia Healthcare by 7,896.1% in the first quarter. Royal Bank of Canada now owns 278,265 shares of the company’s stock valued at $6,508,000 after buying an additional 274,785 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
Recommended Stories
- Five stocks we like better than Acadia Healthcare
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
